title: Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults.
authors.forename: A
authors.initials: A
authors.lastname: Reichle
authors.forename: Th
authors.initials: T
authors.lastname: Vogt
authors.forename: L
authors.initials: L
authors.lastname: Kunz-Schughart
authors.forename: Th
authors.initials: T
authors.lastname: Bretschneider
authors.forename: M
authors.initials: M
authors.lastname: Bachthaler
authors.forename: K
authors.initials: K
authors.lastname: Bross
authors.forename: S
authors.initials: S
authors.lastname: Freund
authors.forename: R
authors.initials: R
authors.lastname: Andreesen
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018432:Drug Resistance, Multiple; D054747:Histiocytic Sarcoma / Q000188:drug therapy*; D006801:Humans; D007783:Lactones / Q000008:administration & dosage; D008297:Male; D000077205:Pioglitazone; D013450:Sulfones / Q000008:administration & dosage; D045162:Thiazolidinediones / Q000008:administration & dosage
chemical_list: D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D007783:Lactones; D013450:Sulfones; D045162:Thiazolidinediones; C116926:rofecoxib; D003520:Cyclophosphamide; C003726:trofosfamide; D000077205:Pioglitazone